Skip to content

APOTHEEK VAN DIONANT: what changed

What changed

APOTHEEK VAN DIONANT

BE 0735.683.929
NACE 47.730, Retail sale of pharmaceutical products
filed annual accounts (NBB)
Financial years compared with
Net result for the year
€44,554
2024 · €34,970+€9,584
Equity
€176,975
2024 · €132,421+€44,554
Cash
€39,869
2024 · €33,992+€5,877
Balance sheet total
€229,148
2024 · €206,568+€22,580

Largest movements

2024 to 2025
Assets
  • Stocks and contracts +€11,053

    up €11,053 (+9.5%), from €116,456 to €127,509

  • Financial fixed assets +€7,241

    new in 2025: €7,241

  • Cash +€5,877

    up €5,877 (+17.3%), from €33,992 to €39,869

    mainly Net result for the year (+€44,554) and Accrued charges and deferred income (+€6,126)

  • Tangible fixed assets -€4,281

    down €4,281 (-22.5%), from €19,029 to €14,748

    of which Plant, machinery and equipment: -€2,406

  • Receivables within one year +€3,029

    up €3,029 (+9.3%), from €32,652 to €35,682

    of which Trade receivables: +€5,647

Equity and liabilities
  • Reserves +€44,554

    up €44,554 (+35.0%), from €127,421 to €171,975

  • Other debts -€29,703

    down €29,703 (-68.8%), from €43,156 to €13,453

  • Accrued charges and deferred income +€6,126

    up €6,126 (+69.3%), from €8,839 to €14,965

  • Tax, wage and social debts +€3,111

    up €3,111 (+246%), from €1,266 to €4,377

Income statement
  • Gross operating margin +€6,082

    up €6,082 (+9.3%), from €65,437 to €71,519

  • Depreciation -€5,919

    down €5,919 (-58.0%), from €10,200 to €4,281

  • Taxes +€3,618

    up €3,618 (+26.2%), from €13,830 to €17,448

  • Financial charges -€2,211

    down €2,211 (-36.1%), from €6,127 to €3,916

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 €34,970
Gross operating margin +€6,082
Staff costs -€332
Depreciation +€5,919
Other operating charges -€25
Financial income -€652
Financial charges +€2,211
Taxes -€3,618
Result 2025 €44,554
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€13,118
Investment -€7,241
Financing €0
Cash 2024 €33,992
Net result for the year +€44,554
Depreciation +€4,281
Stocks and contracts -€11,053
Receivables within one year -€3,029
Deferred charges and accrued income +€339
Trade debts -€1,507
Tax, wage and social debts +€3,111
Other debts -€29,703
Accrued charges and deferred income +€6,126
Investment in fixed assets (net) -€7,241
Cash 2025 €39,869
brings cash intakes cash out
Every line side by side 40 lines
Line Code 2024 2025 Change %
Total assets 20/58 €206,568 €229,148 +€22,580 +10.9%
Fixed assets 21/28 €19,029 €21,989 +€2,960 +15.6%
Tangible fixed assets 22/27 €19,029 €14,748 -€4,281 -22.5%
Plant, machinery and equipment 23 €17,154 €14,748 -€2,406 -14.0%
Furniture and vehicles 24 €1,875 €0 -€1,875 -100%
Financial fixed assets 28 - €7,241 +€7,241
Current assets 29/58 €187,539 €207,159 +€19,620 +10.5%
Stocks and contracts in progress 3 €116,456 €127,509 +€11,053 +9.5%
Stocks 30/36 €116,456 €127,509 +€11,053 +9.5%
Amounts receivable within one year 40/41 €32,652 €35,682 +€3,029 +9.3%
Trade receivables 40 €29,447 €35,094 +€5,647 +19.2%
Other amounts receivable 41 €3,205 €588 -€2,617 -81.7%
Cash at bank and in hand 54/58 €33,992 €39,869 +€5,877 +17.3%
Deferred charges and accrued income 490/1 €4,439 €4,100 -€339 -7.6%
Total equity and liabilities 10/49 €206,568 €229,148 +€22,580 +10.9%
Equity 10/15 €132,421 €176,975 +€44,554 +33.6%
Contributions 10/11 €5,000 €5,000 = 0.0%
Reserves 13 €127,421 €171,975 +€44,554 +35.0%
Distributable reserves 133 €127,421 €171,975 +€44,554 +35.0%
Amounts payable 17/49 €74,147 €52,173 -€21,974 -29.6%
Amounts payable within one year 42/48 €65,308 €37,208 -€28,100 -43.0%
Trade debts 44 €20,886 €19,379 -€1,507 -7.2%
Suppliers 440/4 €20,886 €19,379 -€1,507 -7.2%
Taxes, remuneration and social security 45 €1,266 €4,377 +€3,111 +246%
Taxes 450/3 €1,266 €4,377 +€3,111 +246%
Other amounts payable 47/48 €43,156 €13,453 -€29,703 -68.8%
Accrued charges and deferred income 492/3 €8,839 €14,965 +€6,126 +69.3%
Remuneration, social security and pensions 62 €637 €970 +€332 +52.1%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €10,200 €4,281 -€5,919 -58.0%
Other operating charges 640/8 €1,562 €1,587 +€25 +1.6%
Gross operating margin 9900 €65,437 €71,519 +€6,082 +9.3%
Operating profit (loss) 9901 €53,038 €64,682 +€11,644 +22.0%
Financial income 75/76B €1,889 €1,236 -€652 -34.5%
Recurring financial income 75 €1,889 €1,236 -€652 -34.5%
Financial charges 65/66B €6,127 €3,916 -€2,211 -36.1%
Recurring financial charges 65 €6,127 €3,916 -€2,211 -36.1%
Profit (loss) for the period before taxes 9903 €48,799 €62,002 +€13,203 +27.1%
Income taxes 67/77 €13,830 €17,448 +€3,618 +26.2%
Profit (loss) for the period 9904 €34,970 €44,554 +€9,584 +27.4%
Profit (loss) for the period to be appropriated 9905 €34,970 €44,554 +€9,584 +27.4%
Calculation and sources

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 1 November 2026 via checked.be.